ESC 365 - AFIRE - Rivaroxaban monotherapy versus combination therapy in patients with atrial fibrillation and stable coronary artery disease

ESC Premium Access

AFIRE - Rivaroxaban monotherapy versus combination therapy in patients with atrial fibrillation and stable coronary artery disease

Session: Hot Line Session 3

Topic: Pharmacotherapy

Speaker: Doctor S. Yasuda (Sendai, JP)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Satoshi Yasuda

Tohoku University, Sendai (Japan)

6 presentations

0 follower

14 more presentations in this session

Combined effect of lower LDL-C and lower SBP on the lifetime risk of cardiovascular disease

Speaker: Professor B. Ference (Cambridge, GB)

Discussant review - Combined effect of lower LDL-C and lower SBP on the lifetime risk of cardiovascular disease

Speaker: Professor J. Hopewell (Oxford, GB)

Questions from the audience and discussion

Discussant review - AFIRE

Speaker: Professor F. Verheugt (Amsterdam, NL)

Questions from the audience and discussion

Access the full session

Hot Line Session 3

Speakers: Doctor S. Yasuda, Professor B. Ference, Professor J. Hopewell, Professor F. Verheugt

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources